Publications in collaboration with researchers from Hospital Xeral Calde (133)

2015

  1. Erratum to "Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project" [Semin Arthritis Rheum 44 (2015) 618-626]

    Seminars in Arthritis and Rheumatism

2014

  1. Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients

    Annals of the Rheumatic Diseases

  2. Correlation between two biomarkers of atherosclerosis, osteopontin and angiopoietin-2, in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 32, Núm. 2, pp. 231-236

  3. Gelsolin levels are decreased in ankylosing spondylitis patients undergoing anti-TNF-alpha therapy

    Clinical and Experimental Rheumatology, Vol. 32, Núm. 2, pp. 218-224

  4. Independent relationship of osteoprotegerin concentrations with endothelial activation and carotid atherosclerosis in patients with severe rheumatoid arthritis

    Journal of Rheumatology, Vol. 41, Núm. 3, pp. 429-436

  5. Sex differences in patients with systemic lupus erythematosus from Northwest Spain

    Rheumatology International, Vol. 34, Núm. 1, pp. 11-24

2013

  1. Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 3, pp. 365-371

  2. Antitumour necrosis factor-α therapy modulates angiopoietin-2 serum levels in non-diabetic ankylosing spondylitis patients

    Annals of the Rheumatic Diseases

  3. Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 4, pp. 532-537

  4. Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 5, pp. 749-755

  5. CARD8 rs2043211 (p.C10X) polymorphism is not associated with disease susceptibility or cardiovascular events in spanish rheumatoid arthritis patients

    DNA and Cell Biology, Vol. 32, Núm. 1, pp. 28-33

  6. Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-α therapy

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 6, pp. 913-918

  7. Leptin and visfatin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

    Clinical and Experimental Rheumatology, Vol. 31, Núm. 4, pp. 538-545

  8. SMAD3 rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients

    PLoS ONE, Vol. 8, Núm. 10

2012

  1. Analysis of the Interferon Gamma (rs2430561, +874T/A) Functional Gene Variant in Relation to the Presence of Cardiovascular Events in Rheumatoid Arthritis

    PLoS ONE, Vol. 7, Núm. 10

  2. Angioplastia primaria en el Área Norte de Galicia: cambios asistenciales y resultados tras la implantación del programa PROGALIAM

    Revista Espanola de Cardiologia, Vol. 65, Núm. 4, pp. 341-349

  3. Assessment of cardiovascular risk in rheumatoid arthritis: Impact of the new EULAR recommendations on the score cardiovascular risk index

    Clinical Rheumatology, Vol. 31, Núm. 1, pp. 35-39

  4. Association of the methionine sulfoxide reductase A rs10903323 gene polymorphism with cardiovascular disease in patients with rheumatoid arthritis

    Scandinavian Journal of Rheumatology, Vol. 41, Núm. 5, pp. 350-353

  5. Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients

    DNA and Cell Biology, Vol. 31, Núm. 8, pp. 1412-1417

  6. Carotid ultrasound in the cardiovascular risk stratification of patients with rheumatoid arthritis: When and for whom?

    Annals of the Rheumatic Diseases